USANA Health Sciences, Inc. (USNA)
NYSE: USNA · Real-Time Price · USD
19.52
+0.14 (0.72%)
Apr 28, 2026, 4:00 PM EDT - Market closed
USANA Health Sciences Income Statement
Financials in millions USD. Fiscal year is February - January.
Millions USD. Fiscal year is Feb - Jan.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 3, 2026 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Revenue | 925.26 | 854.5 | 921.01 | 998.6 | 1,186 | Upgrade
|
| Revenue Growth (YoY) | 8.28% | -7.22% | -7.77% | -15.83% | 4.57% | Upgrade
|
| Cost of Revenue | 200.85 | 161.21 | 176.69 | 193.89 | 217.9 | Upgrade
|
| Gross Profit | 724.41 | 693.29 | 744.32 | 804.71 | 968.57 | Upgrade
|
| Selling, General & Admin | 673.54 | 618.72 | 651.25 | 697.1 | 798.37 | Upgrade
|
| Operating Expenses | 673.54 | 618.72 | 651.25 | 697.1 | 798.37 | Upgrade
|
| Operating Income | 50.86 | 74.57 | 93.07 | 107.61 | 170.19 | Upgrade
|
| Interest Expense | -0.84 | -0.28 | -0.26 | -0.19 | -0.06 | Upgrade
|
| Interest & Investment Income | 2.42 | 11.32 | 9.64 | 3.79 | 2.52 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.52 | -1.01 | 0.01 | -2.59 | -2.01 | Upgrade
|
| EBT Excluding Unusual Items | 54.96 | 84.59 | 102.45 | 108.62 | 170.64 | Upgrade
|
| Merger & Restructuring Charges | -6.46 | -8.24 | - | - | - | Upgrade
|
| Impairment of Goodwill | -6.39 | - | - | - | - | Upgrade
|
| Asset Writedown | -0.58 | - | - | - | - | Upgrade
|
| Pretax Income | 41.53 | 76.35 | 102.45 | 108.62 | 170.64 | Upgrade
|
| Income Tax Expense | 30.05 | 34.29 | 38.67 | 39.27 | 54.14 | Upgrade
|
| Earnings From Continuing Operations | 11.48 | 42.06 | 63.79 | 69.35 | 116.51 | Upgrade
|
| Minority Interest in Earnings | -0.72 | -0.03 | - | - | - | Upgrade
|
| Net Income | 10.76 | 42.03 | 63.79 | 69.35 | 116.51 | Upgrade
|
| Net Income to Common | 10.76 | 42.03 | 63.79 | 69.35 | 116.51 | Upgrade
|
| Net Income Growth | -74.40% | -34.11% | -8.02% | -40.48% | -6.54% | Upgrade
|
| Shares Outstanding (Basic) | 19 | 19 | 19 | 19 | 20 | Upgrade
|
| Shares Outstanding (Diluted) | 19 | 19 | 19 | 19 | 20 | Upgrade
|
| Shares Change (YoY) | -3.07% | -0.95% | 0.18% | -5.08% | -4.29% | Upgrade
|
| EPS (Basic) | 0.58 | 2.20 | 3.31 | 3.60 | 5.78 | Upgrade
|
| EPS (Diluted) | 0.58 | 2.19 | 3.30 | 3.59 | 5.73 | Upgrade
|
| EPS Growth | -73.52% | -33.64% | -8.08% | -37.35% | -2.22% | Upgrade
|
| Free Cash Flow | 8.53 | 50.92 | 56.15 | 93.5 | 108.46 | Upgrade
|
| Free Cash Flow Per Share | 0.46 | 2.66 | 2.90 | 4.84 | 5.33 | Upgrade
|
| Gross Margin | 78.29% | 81.13% | 80.81% | 80.58% | 81.64% | Upgrade
|
| Operating Margin | 5.50% | 8.73% | 10.11% | 10.78% | 14.34% | Upgrade
|
| Profit Margin | 1.16% | 4.92% | 6.93% | 6.94% | 9.82% | Upgrade
|
| Free Cash Flow Margin | 0.92% | 5.96% | 6.10% | 9.36% | 9.14% | Upgrade
|
| EBITDA | 83.42 | 89.11 | 105.77 | 121.01 | 183.23 | Upgrade
|
| EBITDA Margin | 9.02% | 10.43% | 11.48% | 12.12% | 15.44% | Upgrade
|
| D&A For EBITDA | 32.56 | 14.54 | 12.7 | 13.39 | 13.04 | Upgrade
|
| EBIT | 50.86 | 74.57 | 93.07 | 107.61 | 170.19 | Upgrade
|
| EBIT Margin | 5.50% | 8.73% | 10.11% | 10.78% | 14.34% | Upgrade
|
| Effective Tax Rate | 72.36% | 44.91% | 37.74% | 36.15% | 31.72% | Upgrade
|
| Advertising Expenses | 43.16 | 4.97 | 4.76 | 5.05 | 12.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.